These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21640714)

  • 1. Aliskiren affects fatty-acid uptake and lipid-related genes in rodent and human cardiomyocytes.
    Rodríguez-Penas D; Feijóo-Bandín S; Lear PV; Mosquera-Leal A; García-Rúa V; Otero MF; Rivera M; Gualillo O; González-Juanatey JR; Lago F
    Biochem Pharmacol; 2011 Sep; 82(5):491-504. PubMed ID: 21640714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
    Iwai M; Kanno H; Tomono Y; Inaba S; Senba I; Furuno M; Mogi M; Horiuchi M
    J Hypertens; 2010 Jul; 28(7):1471-81. PubMed ID: 20543712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential impact of adipokines derived from primary adipocytes of wild-type versus streptozotocin-induced diabetic rats on glucose and fatty acid metabolism in cardiomyocytes.
    Palanivel R; Vu V; Park M; Fang X; Sweeney G
    J Endocrinol; 2008 Dec; 199(3):389-97. PubMed ID: 18787059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice.
    Pöss J; Werner C; Lorenz D; Gensch C; Böhm M; Laufs U
    Basic Res Cardiol; 2010 Nov; 105(6):725-35. PubMed ID: 20857126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes.
    Palanivel R; Fang X; Park M; Eguchi M; Pallan S; De Girolamo S; Liu Y; Wang Y; Xu A; Sweeney G
    Cardiovasc Res; 2007 Jul; 75(1):148-57. PubMed ID: 17499232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes.
    Lear PV; Iglesias MJ; Feijóo-Bandín S; Rodríguez-Penas D; Mosquera-Leal A; García-Rúa V; Gualillo O; Ghè C; Arnoletti E; Muccioli G; Diéguez C; González-Juanatey JR; Lago F
    Endocrinology; 2010 Jul; 151(7):3286-98. PubMed ID: 20410201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes.
    Angin Y; Steinbusch LK; Simons PJ; Greulich S; Hoebers NT; Douma K; van Zandvoort MA; Coumans WA; Wijnen W; Diamant M; Ouwens DM; Glatz JF; Luiken JJ
    Biochem J; 2012 Nov; 448(1):43-53. PubMed ID: 22780108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electromechanical effects of the direct renin inhibitor (aliskiren) on the pulmonary vein and atrium.
    Tsai CF; Chen YC; Lin YK; Chen SA; Chen YJ
    Basic Res Cardiol; 2011 Nov; 106(6):979-93. PubMed ID: 21779913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
    Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
    Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aliskiren, exendin-4, and insulin: their impact on endothelin receptor subtype(s) regulation/binding in type 1 diabetic rat hearts.
    Al Lafi SM; Artinian SB; Boutary SS; Zwainy NS; Bitar KM; Bikhazi AB
    Can J Physiol Pharmacol; 2013 Oct; 91(10):830-8. PubMed ID: 24144054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic observation of mechanically-injured mouse femoral artery reveals an antiinflammatory effect of renin inhibitor.
    Ino J; Kojima C; Osaka M; Nitta K; Yoshida M
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1858-63. PubMed ID: 19778947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of glucose transporters on atrial natriuretic peptide-induced glucose uptake by adult and neonatal cardiomyocytes under oxygenation and hypoxia.
    Sosa V; Carbó R; Guarner V
    Eur J Pharmacol; 2007 Jul; 568(1-3):83-8. PubMed ID: 17537429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
    Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
    Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts.
    Carroll R; Carley AN; Dyck JR; Severson DL
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E900-6. PubMed ID: 15632103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permissive action of protein kinase C-zeta in insulin-induced CD36- and GLUT4 translocation in cardiac myocytes.
    Luiken JJ; Ouwens DM; Habets DD; van der Zon GC; Coumans WA; Schwenk RW; Bonen A; Glatz JF
    J Endocrinol; 2009 May; 201(2):199-209. PubMed ID: 19273501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin is synthesized and secreted by human and murine cardiomyocytes.
    Piñeiro R; Iglesias MJ; Gallego R; Raghay K; Eiras S; Rubio J; Diéguez C; Gualillo O; González-Juanatey JR; Lago F
    FEBS Lett; 2005 Sep; 579(23):5163-9. PubMed ID: 16140297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK1/2 inhibition prevents contraction-induced increase in plasma membrane FAT/CD36 content and FA uptake in rodent muscle.
    Turcotte LP; Raney MA; Todd MK
    Acta Physiol Scand; 2005 Jun; 184(2):131-9. PubMed ID: 15916673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes.
    Iglesias MJ; Piñeiro R; Blanco M; Gallego R; Diéguez C; Gualillo O; González-Juanatey JR; Lago F
    Cardiovasc Res; 2004 Jun; 62(3):481-8. PubMed ID: 15158140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of glucose transporter expression in cardiac myocytes: p38 MAPK is a strong inducer of GLUT4.
    Montessuit C; Rosenblatt-Velin N; Papageorgiou I; Campos L; Pellieux C; Palma T; Lerch R
    Cardiovasc Res; 2004 Oct; 64(1):94-104. PubMed ID: 15364617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.